Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-16

Clinical Trial Update: Evaluation of the Effect of Pulsatile Cuts Stendo3 on Vascular Function Patients With Diabetes Type 2 [NA]

View source ↗

Summary

A completed clinical trial evaluating the effect of Pulsatile Cuts Stendo3 on vascular function in patients with Type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pulsatile Cuts Stendo3

Snippet

Sponsor: University Hospital, Clermont-Ferrand | Conditions: Type 2 Diabetes | NA | Status: COMPLETED